Abrilumab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | integrin alpha-4 beta-7 |
Clinical data | |
Synonyms | AMG 181 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG | |
Chemical and physical data | |
Formula | C6362H9806N1686O2014S52 |
Molar mass | 143.8 kg/mol |
Abrilumab (AMG 181) (INN[1]) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.[2]
This drug was developed by MedImmune.
References
External links
- Having an illness or condition that affects your bowels- Worried about Bowel problems
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.